Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension
Added: 21 июня 2008
Last relative articles:
- Researcher Reports On Noninvasive Device For GERD, Obesity
- MGH Study Confirms Benefit Of Surgery For Gastroesophageal Reflux
- TAK-390MR Phase 3 Data Presented At Digestive Disease Week
- The Features Of Chinese Patients With Reflux Esophagitis
- Astrazeneca Receives First European Approval For Nexium R In Pediatric Gerd
- ASGE Offers Guidelines On Endoscopic Treatment Of Dyspepsia
- Acirc; pound;100m Spent Annually On Pointless Indigestion Drugs By NHS
- Using Newly Approved Device, Doctors Do incision-less GERD Surgery
- Acid Reflux Study Looks At Lifespan Of Sufferers
- Hospitalizations Due To GERD Rose 103 Between 1998 And 2005, USA
Comments: [0] / Post comment:
03 Dec 2008 23:15:40
High-Margin Generic Drugmakers -- An Oxymoron? - Motley Fool
High-Margin Generic Drugmakers -- An Oxymoron? Motley Fool - For instance, last December's launch of Wyeth's (NYSE: WYE) Protonix apparently ended with Teva not selling any more beyond that launch. ...
03 Dec 2008 03:02:58
XenoPort shares dive on disappointing study - Forbes
XenoPort shares dive on disappointing study Forbes, NY - Proton pump inhibitors on the market include AstraZeneca (nyse: AZN - news - people )'s Nexium, Wyeth's Protonix and Takeda Pharmaceutical Industries ...
28 Nov 2008 18:04:48
S&P Picks and Pans: RIMM, Schlumberger, Wyeth - BusinessWeek
S&P Picks and Pans: RIMM, Schlumberger, Wyeth BusinessWeek - ... promising R&D products at the company, which we believe will be needed to offset generic erosion in three older drugs ( Protonix , Effexor and Zosyn). ...
26 Nov 2008 21:05:45
Teva and AstraZeneca's Drama Concludes - Motley Fool
Wall Street Journal Blogs Teva and AstraZeneca's Drama Concludes Motley Fool - When Teva launched an at-risk version of Wyeth's (NYSE: WYE) Protonix last year, it reportedly flooded the market with the drug, and Teva certainly could ... Teva Announces Agreement on Generic Pulmicort Respules Patent ...19 Nov 2008 20:37:35
7 Common Digestive Problems and How to End Them - U.S. News & World Report
U.S. News & World Report 7 Common Digestive Problems and How to End Them U.S. News & World Report, DC - Treatment options include drugs that reduce acid levels, such as the proton pump inhibitors Aciphex, Nexium, Prevacid, Prilosec, and Protonix and the H2 ...19 Nov 2008 17:35:01
Teva Launches Generic of AstraZenecas Pulmicort Respules - Wall Street Journal Blogs
BBC News Teva Launches Generic of AstraZenecas Pulmicort Respules Wall Street Journal Blogs, NY - Last Christmas Eve, Wyeth was caught off guard when Teva launched a generic version of Wyeths big-selling heartburn drug Protonix . ... Double Trouble for AstraZeneca AstraZeneca And Teva Square Off Over Pulmicort19 Nov 2008 08:41:03
Teva Announces Agreement on Allegra® Patent Challenge - WELT ONLINE
WELT ONLINE Teva Announces Agreement on Allegra Patent Challenge WELT ONLINE, Germany - ... including that relating to the generic versions of Allegra , Neurontin , Lotrel and Protonix , the effects of competition on our innovative products, ...18 Nov 2008 09:33:43
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial - WELT ONLINE
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial WELT ONLINE, Germany - ... including that relating to the generic versions of Allegra , Neurontin , Lotrel and Protonix , the effects of competition on our innovative products, ...
12 Nov 2008 16:33:31
UPDATE 1-Nycomed ready for IPO after Daxas drug data - guardian.co.uk
UPDATE 1-Nycomed ready for IPO after Daxas drug data guardian.co.uk, UK - ... which suffered a setback in January with the launch of generic versions of its top-selling heartburn drug Protonix in the United States. ...
11 Nov 2008 22:52:30
AstraZeneca's Ulcer Drug Raised Risks With Clot Drug (Update1) - Bloomberg
eFluxMedia AstraZeneca's Ulcer Drug Raised Risks With Clot Drug (Update1) Bloomberg - s Aciphex; Wyeth's Protonix and Prevacid, sold by Takeda Pharmaceutical Co. Complication rates were similar for each of the proton pump inhibitors, ... Medco study cites dangers of mixing Plavix and PPIs Plavix, Heart Burn Drug Combo Risky for Stent Patients, Study Says Study: Concerns on mixing Plavix, heartburn drugs -Source: http://bloomberg.com/apps/news